Nalaganje...
Double blind study of ispaghula in irritable bowel syndrome.
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo g...
Shranjeno v:
Main Authors: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
1987
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1433676/ https://ncbi.nlm.nih.gov/pubmed/3322956 |
Oznake: |
Označite
Brez oznak, prvi označite!
|